The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
Should you start taking your allergy medicine now? We VERIFY the answer to that and other common questions about allergy treatments.
Live Science on MSN10d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
By clicking on this link, we may receive a commission. Learn more. Nasal decongestant spray can help relieve sinus infection symptoms in the short term. But you should limit your use to no more ...
Scripps News on MSN19d
FDA approves standalone nasal spray to treat depressionA one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback